학술논문

A single-arm, multicenter, phase II trial of osimertinib in patients with epidermal growth factor receptor exon 18 G719X, exon 20 S768I, or exon 21 L861Q mutations

Document Type

Article

Author

Villaruz, L.C.; Wang, X.; Bertino, E.M.; Gu, L.; Antonia, S.J.; Burns, T.F.; Clarke, J.; Crawford, J.; Evans, T.L.; Friedland, D.M.; Otterson, G.A.; Ready, N.E.; Wozniak, A.J.; Stinchcombe, T.E.

Source

In ESMO Open April 2023 8(2)

Subject

Language

ISSN

2059-7029

Online Access

Full Text (ScienceDirect 종량제) Full Text (Clinical Key) Full Text (ScienceDirect O/A) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일

부산대학교 도서관

Online Access

메일 발송